Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹298 Cr
P/E Ratio
41.63
P/B Ratio
8.18
Industry P/E
37.5
Debt to Equity
0.04
ROE
54.08 %
ROCE
55.32 %
Div. Yield
0 %
Book Value
30.7
EPS
6.13
CFO
₹17.25 Cr
EBITDA
₹-58.35 Cr
Net Profit
₹-83.16 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Sanjivani Pa
| -35.37 | -1.47 | -29.62 | 63.76 | 57.34 | 97.93 | 30.27 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2018
|
|
|---|---|---|---|---|---|
|
Sanjivani Pa
| 111.46 | 362.98 | 3.46 | 263.00 | -32.73 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 430.45 | 7,004.90 | 25.53 | 12.5 | |
| 5,218.00 | 8,680.23 | 36.69 | 43.77 | |
| 668.50 | 6,569.59 | 74.41 | 4.01 | |
| 653.00 | 6,015.92 | 22.32 | 12.68 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1994
Chairman
Ashwani Khemka
Managing Director
Ashwani Khemka
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Sanjivani Paranteral Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Sanjivani Paranteral Ltd stood at ₹ 48 Cr as on 31-Dec-24
The share price of Sanjivani Paranteral Ltd is ₹251.05 (BSE) as of 17-Apr-2025 IST. Sanjivani Paranteral Ltd has given a return of 57.34% in the last 3 years.
Sanjivani Paranteral Ltd has a market capitalisation of ₹ 298 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Sanjivani Paranteral Ltd is 8.18 times as on 17-Apr-2025, a 61% premium to its peers’ median range of 5.09 times.
The P/E ratio of Sanjivani Paranteral Ltd is 41.63 times as on 17-Apr-2025, a 11% premium to its peers’ median range of 37.50 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sanjivani Paranteral Ltd and enter the required number of quantities and click on buy to purchase the shares of Sanjivani Paranteral Ltd.
Manufacture of allopathic pharmaceutical preparations
The promoter of Sanjivani Paranteral Ltd is Ashwani Khemka. Ashwani Khemka owns 27.13 per cent of the total equity. The chairman of the company is Ashwani Khemka , and the managing director is Ashwani Khemka..
There is no promoter pledging in Sanjivani Paranteral Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,680
|
|
|
7,005
|
|
|
6,570
|
|
|
6,016
|
| Sanjivani Paranteral Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
23.96
|
|
Operating margin(%)
|
14.24
|
|
Net Margin(%)
|
10.92
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Sanjivani Paranteral Ltd was ₹7 Cr.
₹0.75
(
